Description: Nanjing Vazyme Biotech Co., Ltd., a biotechnology company, engages in the research, development, and production of enzymes, antigens, antibodies, and high-molecular organic materials. The company offers scientific reagents, such as PCR and qPCR series, cloning/point mutation, nucleic acid electrophoresis and extraction, reverse transcription, cell series, gene editing, instant granule, protein, hot start, and isothermal amplification series; high-throughput reagents, including DNA and RNA library, single cell epigenetic, magnetic, quantitative series, and capture series; molecular diagnostic reagents; and biomedical reagents and services. It serves scientific research institutions, high-throughput sequencing service companies, molecular diagnostic reagent manufacturers, pharmaceutical companies, CRO companies, hospitals, and other medical institutions. Nanjing Vazyme Biotech Co., Ltd. was founded in 2012 and is based in Nanjing, China.
Home Page: www.vazyme.com
East Section of Building C1-2
Nanjing,
210033
China
Phone:
86 25 8577 1179
Officers
| Name | Title |
|---|---|
| Mr. Lin Cao | Chairman, GM & Core Technician |
| Mr. Lijun Zhang | Deputy GM, Core Technician & Director |
| Mr. Bo Tang | Director & Core Technician |
| Mr. Jin Huang | Board Sec. |
| Mr. Xiaoyu Xu | Deputy GM & Core Technician |
Exchange: SHG
Country: CN : China
Currency: Renminbi (¥)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 26.1211 |
| Price-to-Book MRQ: | 5.4929 |
| Price-to-Sales TTM: | 9.0553 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 2380 |